IL33 and neoplasm: Tumour‐derived IL‐33 dramatically enhances neo‐angiogenesis by increasing endothelial cell proliferation, migration and differentiation into blood vessels to robustly increase metastatic spreading of CRC cells to the liver (Zhang et al., 2016).